New malaria vaccine effective in clinical trial
University of Tübingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria PfSPZ-CVac has been up to 100 percent effective ...
Feb 15, 2017
0
24